Resources

The Financial Advisory Strategy Taskforce (FAST), led by PATH with support from Coefficient Giving and GiveWell, is a multi-country initiative to provide targeted technical assistance to ministries of health to respond to funding disruptions. The program aims to equip countries with data-driven insights to optimize existing funding and commodity flows for maximum impact, along with providing strategic planning tools and technical support to respond to the acute funding crisis.This fact sheet describes the FAST initiative in the Democratic Republic of the Congo (DRC), where it supports the Ministry of Health in responding to funding reductions through evidence-based planning and strategic resource allocation. It highlights the project's key priority areas, core objectives, and major achievements to date.Learn more about FAST here.

The Financial Advisory Strategy Taskforce (FAST), led by PATH with support from Coefficient Giving and GiveWell, is a multi-country initiative to provide targeted technical assistance to ministries of health to respond to funding disruptions. The program aims to equip countries with data-driven insights to optimize existing funding and commodity flows for maximum impact, along with providing strategic planning tools and technical support to respond to the acute funding crisis.This fact sheet describes the FAST initiative in Mozambique, where it supports the Ministry of Health in responding to funding reductions through evidence-based planning and strategic resource allocation. It highlights the project's key priority areas, core objectives, and major achievements to date.Available in English and Portuguese.Learn more about FAST here.

On July 30, 2026, PATH held a webinar on innovative approaches to building demand for malaria vaccines through community engagement. Speakers highlighted early insights and lessons learned, with a focus on driving uptake of all four doses.Featured speakers included:Cindy Bergstrom, World Health OrganizationMarie Nzita Ndambi, National Health Communication Program, Kongo Central Province, Democratic Republic of the CongoEleonora Genovese, Gavi, the Vaccine AllianceThis was the third instance in a quarterly webinar series this year on learnings from malaria vaccine rollout in Africa. Explore resources from all of PATH's malaria vaccine webinars here.

This slide provides a snapshot of the Group B Streptococcus (GBS) vaccine technology landscape, in the effort to track the development of GBS vaccine candidates and provide a summary of the various vaccine approaches being worked on around the world.This snapshot pairs with the GBS Vaccine Clinical Trial Tracker, which provides publicly available information on clinical trials of GBS vaccine candidates intended for disease prevention.To share any updates or corrections to the snapshot, please contact gbssnapshot@path.org.

This spreadsheet provides publicly available information on clinical trials of Group B Streptococcus (GBS) candidate vaccines intended for disease prevention.Sources of information for these trials include clinicaltrials.gov, who.int/clinical-trials-registry-platform, clinicaltrialsregister.eu, chictr.org.cn, and anzctr.org.au.Some information is also obtained through contact with investigators, sponsors, and funders of vaccine clinical trials. This spreadsheet pairs with the GBS Vaccine Snapshot, which provides a summary of the GBS vaccine candidates in development worldwide.To share any updates or corrections to the tracker, please contact gbssnapshot@path.org.